AMRX - Amneal Pharmaceuticals Inc. (AMRX) Q1 2024 Earnings Call Transcript
2024-05-03 13:37:08 ET
Amneal Pharmaceuticals, Inc. (AMRX)
Q1 2024 Results Earnings Conference Call
May 3, 2024, 08:30 AM ET
Company Participants
Tony DiMeo - Head of Investor Relations
Chirag Patel - President and Co-Chief Executive Officer
Chintu Patel - Co-Chief Executive Officer
Tasos Konidaris - Executive Vice President and Chief Financial Officer
Joe Renda - Senior Vice President, Chief Commercial Officer, Specialty
Conference Call Participants
Nathan Rich - Goldman Sachs
Leszek Sulewski - Truist Securities
David Amsellem - Piper Sandler
Balaji Prasad - Barclays Capital
Chris Schott - J.P. Morgan
Presentation
Operator
Good morning and welcome to Amneal Pharmaceuticals First Quarter 2024 Earnings Call. I will now turn the call over to Amneal's Head of Investor Relations, Tony DiMeo.
Tony DiMeo
Good morning. And thank you for joining Amneal Pharmaceuticals first quarter 2024 earnings call. Today, we issued a press release reporting Q1 results. The earnings press release and presentation are available at amneal.com.
Certain statements made on this call regarding matters that are not historical facts, including, but not limited to, management's outlook or predictions, are forward-looking statements that are based solely on information that is now available to us. Please see the section entitled Cautionary Statements on Forward-Looking Statements for factors that may impact future performance.
We also discuss non-GAAP measures. Information on use of these measures and reconciliations to GAAP are in the earnings release and presentation.
On the call today are Chirag and Chintu Patel, Co-Founders and Co-CEOs; Tasos Konidaris, CFO; our commercial leaders, Andy Boyer for Generics, Joe Renda for Specialty; and Jason Daly, Chief Legal Officer....
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript